Dechert represented abrdn in the transaction. abrdn Inc., the U.S. subsidiary of global investment company abrdn, entered into an agreement to acquire the healthcare fund management capabilities...
You must be a Standard 1 Year member to access this content.
Dechert LLP represented abrdn in the transaction. abrdn announced its acquisition of the U.S. closed-end funds sponsored by Macquarie/Delaware Investments. The transaction involved the reorganization of...
You must be a Standard 1 Year member to access this content.
Dechert advised One Equity Partners and Rizing in OEP’s definitive agreement to sell Rizing LLC to Wipro Limited, which was advised by AZB. One Equity Partners is...
You must be a Standard 1 Year member to access this content.
ArentFox Schiff represented Chesapeake Eyecare and Laser Center on the matter. Dechert advised Centre Partners and its portfolio company, Vision Innovation Partners. Chesapeake Eyecare and Laser...
You must be a Standard 1 Year member to access this content.
Sheppard Mullin advised the UrgentMED on the deal, while Dechert advised Quilvest Capital Partners. The UrgentMED group companies, an independent network of 35 urgent care clinics...
You must be a Standard 1 Year member to access this content.
Dechert has advised MiddleGround Capital on the deal. MiddleGround executed its acquisition of Plasman Holdings, a single-source solutions provider to automotive original equipment manufacturers for exterior...
You must be a Standard 1 Year member to access this content.
Dechert advised Quest Diagnostics in the transaction. Quest Diagnostics completed the sale of its ownership interest in Q2 Solutions, a global leader in central laboratory services...
You must be a Standard 1 Year member to access this content.
